Literature DB >> 23436563

Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study.

Mark E Scott1, Yurii B Shvetsov, Pamela J Thompson, Brenda Y Hernandez, Xuemei Zhu, Lynne R Wilkens, Jeffrey Killeen, Dien D Vo, Anna-Barbara Moscicki, Marc T Goodman.   

Abstract

Mechanisms for the control and resolution of human papillomavirus (HPV) infection of the cervix include the local production of cytokines, which control recruitment and function of cells integral to pathogen control. We established a cohort of women for long-term follow-up to examine the mucosal expression of antiviral (IFN-α2), Type-1 (IFN-γ, IL-12), regulatory (IL-10), and proinflammatory (IL-1α, IL-1β, IL-6, IL-8, MIP-1α, and TNF) cytokines in association with the clearance of incident cervical HPV infection. Interviews and specimens for HPV DNA analysis and cytokine protein measurement were obtained at baseline and at 4-month intervals. A Cox proportional hazards model was used to study the relationship between clearance of 107 high-risk and 111 low-risk incident HPV infections and cytokine levels among 154 women. Positive changes from baseline levels of IL-10, IL-12, MIP-1α, and TNF were associated with significantly longer times to type-specific HPV clearance. Inverse trends in the hazard ratios associated with clearance of high-risk HPV infections were monotonic and significant for IL-12 (ptrend  = 0.02) and TNF (ptrend  = 0.02); the likelihood of high-risk HPV clearance was reduced by 65% and 67%, respectively, among women in the highest as compared with the lowest quartile of change from baseline. Our results suggest that in women with a nontransient cervical HPV infection, proinflammatory, Type-1, and regulatory cytokines are elevated, underscoring the long-term commitment of local immune mediators to viral eradication.
Copyright © 2013 UICC.

Entities:  

Keywords:  cervix; cytokines; human papillomavirus; interleukins

Mesh:

Substances:

Year:  2013        PMID: 23436563      PMCID: PMC3732505          DOI: 10.1002/ijc.28119

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  49 in total

Review 1.  Immune evasion in human papillomavirus-associated cervical cancer.

Authors:  Robert W Tindle
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 2.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

Review 3.  The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease.

Authors:  K J O'Byrne; A G Dalgleish; M J Browning; W P Steward; A L Harris
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

Review 4.  Immune responses to human papillomavirus.

Authors:  Margaret Stanley
Journal:  Vaccine       Date:  2006-03-30       Impact factor: 3.641

5.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.

Authors:  Jeanette Reiser; José Hurst; Maike Voges; Peter Krauss; Peter Münch; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion.

Authors:  Mark Lucas; Lynda M Stuart; John Savill; Adam Lacy-Hulbert
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

8.  Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.

Authors:  Marc T Goodman; Yurii B Shvetsov; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Pamela J Thompson; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Brenda Y Hernandez
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

9.  Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.

Authors:  Rezaul Karim; Craig Meyers; Claude Backendorf; Kristina Ludigs; Rienk Offringa; Gert-Jan B van Ommen; Cornelis J M Melief; Sjoerd H van der Burg; Judith M Boer
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

Review 10.  Chronic immune activation and inflammation as the cause of malignancy.

Authors:  K J O'Byrne; A G Dalgleish
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

View more
  36 in total

1.  Genital inflammation and the risk of HIV acquisition in women.

Authors:  Lindi Masson; Jo-Ann S Passmore; Lenine J Liebenberg; Lise Werner; Cheryl Baxter; Kelly B Arnold; Carolyn Williamson; Francesca Little; Leila E Mansoor; Vivek Naranbhai; Douglas A Lauffenburger; Katharina Ronacher; Gerhard Walzl; Nigel J Garrett; Brent L Williams; Mara Couto-Rodriguez; Mady Hornig; W Ian Lipkin; Anneke Grobler; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  Clin Infect Dis       Date:  2015-04-21       Impact factor: 9.079

Review 2.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

3.  The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.

Authors:  Nadja Vielot; Michael G Hudgens; Nelly Mugo; Michael Chitwa; Joshua Kimani; Jennifer Smith
Journal:  Sex Transm Dis       Date:  2015-06       Impact factor: 2.830

4.  Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.

Authors:  Lindi Masson; Kelly B Arnold; Francesca Little; Koleka Mlisana; David A Lewis; Nonhlanhla Mkhize; Hoyam Gamieldien; Sinaye Ngcapu; Leigh Johnson; Douglas A Lauffenburger; Quarraisha Abdool Karim; Salim S Abdool Karim; Jo-Ann S Passmore
Journal:  Sex Transm Infect       Date:  2015-10-28       Impact factor: 3.519

5.  The effect of intrauterine devices on acquisition and clearance of human papillomavirus.

Authors:  Sarah H Averbach; Yifei Ma; Karen Smith-McCune; Stephen Shiboski; Anna B Moscicki
Journal:  Am J Obstet Gynecol       Date:  2016-12-14       Impact factor: 8.661

6.  Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.

Authors:  Dan Song; Hong Li; Haibo Li; Jianrong Dai
Journal:  Oncol Lett       Date:  2015-05-29       Impact factor: 2.967

7.  Diversity of Cervicovaginal Cytokine Response to Incident Chlamydia trachomatis Infection Among a Prospective Cohort of Young Women.

Authors:  Loris Y Hwang; Mark E Scott; Yifei Ma; Anna-Barbara Moscicki
Journal:  Am J Reprod Immunol       Date:  2015-05-20       Impact factor: 3.886

8.  Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia.

Authors:  Takashi Iwata; Takuma Fujii; Kenji Morii; Miyuki Saito; Juri Sugiyama; Hiroshi Nishio; Tohru Morisada; Kyoko Tanaka; Tomonori Yaguchi; Yutaka Kawakami; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2014-03-01       Impact factor: 3.402

9.  Association of serum cytokines with oral HPV clearance.

Authors:  Jennifer O Lam; Jay H Bream; Elizabeth A Sugar; Christian L Coles; Kathleen M Weber; Robert D Burk; Dorothy J Wiley; Ross D Cranston; Susheel Reddy; Joseph B Margolick; Howard D Strickler; Alicia Wentz; Lisa Jacobson; Yingshi Guo; Weihong Xiao; Maura L Gillison; Gypsyamber D'Souza
Journal:  Cytokine       Date:  2016-04-08       Impact factor: 3.861

10.  Biomarkers of oral inflammation in perinatally HIV-infected and perinatally HIV-exposed, uninfected youth.

Authors:  Anna-Barbara Moscicki; Tzy-Jyun Yao; Jonathan S Russell; Sepideh Farhat; Mark Scott; Larry Magpantay; Gordana Halec; Caroline H Shiboski; Mark I Ryder
Journal:  J Clin Periodontol       Date:  2019-09-05       Impact factor: 8.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.